CytoDyn Inc.
CYDY
$0.3172
$0.00722.32%
OTC PK
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.50% | -34.13% | |||
| Depreciation & Amortization | -380.00% | 25.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.56% | 7.98% | |||
| Operating Income | -26.56% | -7.98% | |||
| Income Before Tax | -25.18% | 0.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.18% | 0.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.18% | 0.21% | |||
| EBIT | -26.56% | -7.98% | |||
| EBITDA | -26.61% | -7.97% | |||
| EPS Basic | -21.43% | 0.00% | |||
| Normalized Basic EPS | -15.38% | -4.00% | |||
| EPS Diluted | -83.33% | 0.00% | |||
| Normalized Diluted EPS | -15.38% | -4.00% | |||
| Average Basic Shares Outstanding | 0.90% | 0.56% | |||
| Average Diluted Shares Outstanding | 0.90% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||